Alkermes (company)
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and manufacturing facilities in Athlone, Ireland, and Wilmington, Ohio.
| Company type | Public |
|---|---|
Traded as |
|
| Industry | Biotechnology |
| Founded | 1987 |
| Founder | Michael Wall |
| Headquarters | , |
Key people | Richard Pops (CEO) |
| Revenue | US$1.1 billion (2022) |
| US$-20.5 million | |
Net income | US$-158 million (2022) |
| Total assets | US$1.9 billion |
| Total equity | US$1 billion |
Number of employees | 2,100 |
| Website | www.alkermes.com |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.